Bramshill Investments’s Fortress Biotech 9.375% Series A Preferred Stock FBIOP Stock Holding History

Bramshill Investments’s Portfolio FBIOP Stock Details FBIOP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-33,424	Closed	-$648K	–	191
2020 Q4	$648K	Buy	+33,424	New	+$628K	0.04%	111

Other funds holding FBIOP

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

PCG

Private Capital Group West Hartford, Connecticut $133M AUM 11.23% 1-Year Est. Return

Bramshill Investments's FBIOP Position: Q1 2021 in Review

Bramshill Investments sold out of Fortress Biotech 9.375% Series A Preferred Stock (FBIOP) in Q1 2021, closing a stake of 33,424 shares — an estimated $648K sold.

Bramshill Investments first reported a position in FBIOP in Q4 2020 and held it in 1 quarter. The position peaked at $648K in Q4 2020. 3 funds tracked by Wall St. Rank hold FBIOP as of Q1 2021.

Bramshill Investments reported no remaining Fortress Biotech 9.375% Series A Preferred Stock position as of Q1 2021 after selling out during the quarter.
Bramshill Investments sold 33,424 Fortress Biotech 9.375% Series A Preferred Stock shares in Q1 2021, an estimated $648K.
Bramshill Investments first reported a position in Fortress Biotech 9.375% Series A Preferred Stock in Q4 2020 and held it in 1 quarter.
Bramshill Investments's Fortress Biotech 9.375% Series A Preferred Stock position peaked at $648K in Q4 2020.
3 funds tracked by Wall St. Rank held Fortress Biotech 9.375% Series A Preferred Stock as of Q1 2021.

Based on Bramshill Investments's 13F filing for Q1 2021, filed 17 May 2021.